Gsk (GSK) Enterprise Value (2009 - 2026)
Gsk (GSK) posted Enterprise Value of -$4.7 billion for Q4 2025, up 8.37% on a QoQ basis from -$5.1 billion in Q4 2024, and up 8.37% year-over-year from -$4.3 billion in Q4 2024.
Gsk (GSK) has 11 years of Enterprise Value data on file, last reported at -$4.7 billion in Q4 2025.
- In Q4 2025, Enterprise Value rose 8.37% year-over-year to -$4.7 billion; the TTM figure through Dec 2025 stood at -$4.7 billion (up 8.37% YoY), while the FY2025 annual figure was -$4.7 billion, up 8.37% from the prior year.
- Enterprise Value rose to -$4.7 billion in Q4 2025, from -$5.1 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.7 billion in Q4 2025 and bottomed at -$9.2 billion in Q4 2022.
- A 5-year average of -$6.2 billion and a median of -$5.8 billion in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value jumped 32.29% — and 2022, when it slumped 59.0%.
- Year by year, Enterprise Value stood at -$5.8 billion in 2021, then slumped by 59.0% to -$9.2 billion in 2022, then soared by 30.36% to -$6.4 billion in 2023, then grew by 19.95% to -$5.1 billion in 2024, then increased by 8.37% to -$4.7 billion in 2025.
- The last three Enterprise Value figures came in at -$4.7 billion (Q4 2025), -$5.1 billion (Q4 2024), and -$6.4 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.96 Bn |
| Dec 31, 2025 | -5.24 Bn |
| Sep 30, 2025 | -4.83 Bn |
| Jun 30, 2025 | -5.65 Bn |
| Mar 31, 2025 | -6.38 Bn |
| Dec 31, 2024 | -5.86 Bn |
| Sep 30, 2024 | -4.87 Bn |
| Jun 30, 2024 | -4.37 Bn |
| Mar 31, 2024 | -4.23 Bn |
| Dec 31, 2023 | -7.06 Bn |
| Sep 30, 2023 | -4.86 Bn |
| Jun 30, 2023 | -4.80 Bn |
| Mar 31, 2023 | -4.28 Bn |
| Dec 31, 2022 | -9.75 Bn |
| Sep 30, 2022 | -4.38 Bn |
| Jun 30, 2022 | -382.83 Mn |
| Mar 31, 2022 | -6.03 Bn |
| Dec 31, 2021 | 2.71 Bn |
| Sep 30, 2021 | 3.69 Bn |
| Jun 30, 2021 | 3.63 Bn |
| Mar 31, 2021 | 1.59 Bn |
| Dec 31, 2020 | -294.46 Mn |
| Sep 28, 2020 | -10.34 Bn |
| Jun 30, 2020 | -2.54 Bn |
| Mar 31, 2020 | 1.27 Bn |
| Dec 31, 2019 | 2.78 Bn |
| Sep 30, 2019 | 1.81 Bn |
| Jun 30, 2019 | -5.81 Bn |
| Mar 31, 2019 | -5.89 Bn |
| Dec 31, 2018 | -5.98 Bn |
| Sep 30, 2018 | -5.84 Bn |
| Jun 30, 2018 | -6.52 Bn |
| Mar 31, 2018 | -691.35 Mn |
| Dec 31, 2017 | -456.72 Mn |
| Sep 30, 2017 | -1.31 Bn |
| Jun 30, 2017 | -353.95 Mn |
| Mar 31, 2017 | -572.30 Mn |
| Dec 31, 2016 | -1.51 Bn |
| Sep 30, 2016 | -728.28 Mn |
| Jun 30, 2016 | -456.71 Mn |
| Mar 31, 2016 | -1.83 Bn |
| Dec 31, 2015 | -2.90 Bn |
| Sep 30, 2015 | -5.10 Bn |
| Jun 30, 2015 | -6.24 Bn |
| Mar 31, 2015 | -9.40 Bn |
| Dec 31, 2014 | -5.17 Bn |
| Sep 30, 2014 | -5.27 Bn |
| Jun 30, 2014 | -3.95 Bn |
| Mar 31, 2014 | -4.31 Bn |
| Dec 31, 2013 | -7.89 Bn |
| Sep 30, 2013 | -4.00 Bn |
| Jun 30, 2013 | -3.28 Bn |
| Mar 31, 2013 | -4.71 Bn |
| Dec 31, 2012 | -6,423.36 Bn |
| Sep 30, 2012 | -3.96 Bn |
| Jun 30, 2012 | -10.64 Bn |
| Mar 31, 2012 | -7.74 Bn |
| Dec 31, 2011 | -12,572.24 Bn |
| Sep 30, 2011 | -7.16 Bn |
| Jun 30, 2011 | -7.95 Bn |
| Mar 31, 2011 | -8.82 Bn |
| Dec 31, 2010 | -7.92 Bn |
| Sep 30, 2010 | -8.05 Bn |
| Jun 30, 2010 | -8.34 Bn |
| Mar 31, 2010 | -9.49 Bn |
| Dec 31, 2009 | -9.21 Bn |
| Sep 30, 2009 | -10.50 Bn |
| Jun 30, 2009 | -7.17 Bn |
| Mar 31, 2009 | -8.78 Bn |